Calcium folinate pentahydrate
Appendiceal Neoplasms
Ciusss de L'Est de l'Île de MontréalSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Appendiceal Neoplasms cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nilotinib National Cancer Institute (NCI) | Phase 2 | B |
FLUOROURACILUM Ciusss de L'Est de l'Île de Montréal | Phase 2 | B |
Eloxatin Koen Rovers | Phase 2 | B |
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →